TOLNAFTATE

TOLNAFTATE was reported 1311 times

TOLNAFTATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN MESOTHELIOMA 1 0.1429
1 BEZOLD ABSCESS 1 0.1429
2 MESOTHELIOMA MALIGNANT 23 0.0623
3 BRONCHITIS PNEUMOCOCCAL 1 0.0476
4 TOOTH HYPOPLASIA 8 0.0460
5 NONALCOHOLIC FATTY LIVER DISEASE 7 0.0357
6 ENAMEL ANOMALY 8 0.0280
7 MESOTHELIOMA 36 0.0277
8 ANTI-PLATELET ANTIBODY 1 0.0270
9 SARCOMATOID MESOTHELIOMA 2 0.0267
10 BLOOD URIC ACID DECREASED 10 0.0206
11 ARTERIAL STENOSIS LIMB 1 0.0196
12 EXPOSURE TO CHEMICAL POLLUTION 31 0.0184
13 PRODUCT IMPURITY 5 0.0182
14 PARAPROTEINAEMIA 5 0.0161
15 HYPERTROPHY 8 0.0147
16 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
17 PLEURAL MESOTHELIOMA MALIGNANT 4 0.0129
18 ASBESTOSIS 3 0.0106
19 BLOOD VISCOSITY ABNORMAL 1 0.0105
20 PRODUCT ADVERTISING ISSUE 2 0.0093
21 NON-ALCOHOLIC FATTY LIVER 3 0.0089
22 ABDOMINAL WALL CYST 1 0.0082
23 LATEX ALLERGY 2 0.0081
24 ANAL ERYTHEMA 1 0.0080
25 ASPIRATION BONE MARROW 1 0.0075
26 BLADDER CYST 1 0.0062
27 SKIN CANDIDA 3 0.0057
28 EPITHELIOID MESOTHELIOMA 2 0.0057
29 OESOPHAGEAL MOTILITY DISORDER 2 0.0056
30 LID SULCUS DEEPENED 2 0.0054
31 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 7 0.0050
32 BLOOD IMMUNOGLOBULIN M INCREASED 3 0.0049
33 SKIN NODULE 2 0.0049
34 AUTOMATISM 1 0.0046
35 TINEA PEDIS 7 0.0044
36 MUCORMYCOSIS 11 0.0042
37 BLOOD CREATININE DECREASED 13 0.0041
38 HEPATOSPLENOMEGALY 10 0.0039
39 ADNEXA UTERI MASS 1 0.0035
40 NERVE ROOT COMPRESSION 2 0.0035
41 ABDOMINAL WALL DISORDER 1 0.0034
42 ANOGENITAL WARTS 3 0.0034
43 BIOPSY LIVER ABNORMAL 1 0.0033
44 VARICES OESOPHAGEAL 10 0.0033
45 BREAST CELLULITIS 1 0.0032
46 MITRAL VALVE CALCIFICATION 2 0.0031
47 OESOPHAGEAL ACHALASIA 2 0.0031
48 BLOOD VISCOSITY DECREASED 1 0.0030
49 ACQUIRED OESOPHAGEAL WEB 1 0.0029
50 CARBON DIOXIDE INCREASED 4 0.0029
51 ANION GAP DECREASED 1 0.0029
52 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
53 BIPOLAR II DISORDER 1 0.0028
54 BITE 2 0.0028
55 CANCER PAIN 7 0.0027
56 TINEA INFECTION 3 0.0027
57 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
58 PSEUDOMONAS TEST POSITIVE 2 0.0024
59 BOTULISM 2 0.0024
60 ADRENAL MASS 2 0.0024
61 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
62 PRODUCT CONTAMINATION 8 0.0022
63 RECALLED PRODUCT ADMINISTERED 21 0.0022
64 EXPOSURE TO TOXIC AGENT 7 0.0022
65 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
66 PHYSICAL DISABILITY 9 0.0020
67 ONYCHALGIA 2 0.0020
68 BLEPHARAL PIGMENTATION 1 0.0020
69 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
70 NEOPLASM SKIN 3 0.0019
71 CONSCIOUSNESS FLUCTUATING 2 0.0019
72 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
73 HYPERSENSITIVITY VASCULITIS 5 0.0019
74 STRESS URINARY INCONTINENCE 2 0.0019
75 INSTILLATION SITE REACTION 2 0.0018
76 NAIL GROWTH ABNORMAL 2 0.0018
77 BODY TINEA 1 0.0018
78 CYTOGENETIC ABNORMALITY 2 0.0018
79 CERVICAL SPINAL STENOSIS 3 0.0017
80 CHEMICAL BURN 2 0.0017
81 FLAT AFFECT 4 0.0017
82 NEPHROGENIC ANAEMIA 8 0.0017
83 STREPTOCOCCAL SEPSIS 2 0.0017
84 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
85 ADRENAL ADENOMA 1 0.0017
86 ANTEROGRADE AMNESIA 1 0.0017
87 CHRONIC RESPIRATORY FAILURE 2 0.0017
88 BLOOD HIV RNA INCREASED 3 0.0017
89 INFLAMMATORY MARKER INCREASED 8 0.0016
90 APPLICATION SITE WARMTH 2 0.0016
91 ANAL INFLAMMATION 1 0.0016
92 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
93 ARACHNOIDITIS 1 0.0014
94 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
95 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
96 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
97 BORDERLINE PERSONALITY DISORDER 1 0.0014
98 AUDITORY DISORDER 2 0.0014
99 JUDGEMENT IMPAIRED 2 0.0014
100 BACTERIAL DISEASE CARRIER 1 0.0014
101 ATROPHIC VULVOVAGINITIS 1 0.0014
102 AORTIC VALVE SCLEROSIS 1 0.0014
103 BLUNTED AFFECT 1 0.0014
104 REBOUND ACID HYPERSECRETION 4 0.0013
105 JOINT EFFUSION 9 0.0013
106 ASPIRATION PLEURAL CAVITY 1 0.0013
107 BREAST FEEDING 1 0.0013
108 BLISTER INFECTED 1 0.0013
109 WOUND SECRETION 5 0.0013
110 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
111 INTRA-UTERINE DEATH 2 0.0012
112 BARRETT'S OESOPHAGUS 1 0.0012
113 DRUG ADMINISTERED AT INAPPROPRIATE SITE 13 0.0012
114 BALANOPOSTHITIS 1 0.0012
115 BILIARY DYSKINESIA 2 0.0012
116 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
117 ABDOMINAL LYMPHADENOPATHY 1 0.0012
118 CAROTID ARTERY STENOSIS 4 0.0011
119 ABDOMINAL SEPSIS 1 0.0011
120 MITRAL VALVE DISEASE 2 0.0011
121 MUSCLE CRAMP 2 0.0011
122 ABDOMINAL NEOPLASM 1 0.0011
123 BLOOD MAGNESIUM INCREASED 1 0.0011
124 METASTATIC RENAL CELL CARCINOMA 2 0.0011
125 RED BLOOD CELL COUNT INCREASED 3 0.0011
126 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
127 DENTAL CARE 2 0.0011
128 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
129 APPLICATION SITE DERMATITIS 1 0.0011
130 LIP DISORDER 2 0.0011
131 PHARYNGEAL DISORDER 3 0.0010
132 TRAUMATIC LUNG INJURY 2 0.0010
133 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
134 AUTONOMIC NEUROPATHY 1 0.0010
135 BREAST ABSCESS 1 0.0010
136 RENAL MASS 2 0.0010
137 SKIN INDURATION 2 0.0010
138 ABSCESS JAW 1 0.0010
139 ONYCHOMADESIS 4 0.0010
140 APPLICATION SITE PAPULES 1 0.0009
141 ALLERGY TO ANIMAL 1 0.0009
142 CERVICAL DYSPLASIA 2 0.0009
143 DANDRUFF 2 0.0009
144 GASTROINTESTINAL ULCER 2 0.0009
145 BLOOD CREATININE ABNORMAL 3 0.0009
146 ACUTE PRERENAL FAILURE 1 0.0009
147 BLOOD POTASSIUM INCREASED 14 0.0009
148 ALLODYNIA 1 0.0009
149 BILE DUCT STENOSIS 1 0.0008
150 SLOW SPEECH 2 0.0008
151 HEART INJURY 2 0.0008
152 INFREQUENT BOWEL MOVEMENTS 2 0.0008
153 AMPUTATION 1 0.0008
154 HYPERPARATHYROIDISM SECONDARY 2 0.0008
155 CHEMICAL BURN OF SKIN 2 0.0008
156 BLOOD CHLORIDE DECREASED 2 0.0008
157 VIRAL LOAD INCREASED 3 0.0008
158 LIPOMA 2 0.0008
159 NAIL DISCOLOURATION 3 0.0008
160 DEFORMITY 7 0.0007
161 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
162 INTRACRANIAL ANEURYSM 3 0.0007
163 FUNGAL SKIN INFECTION 3 0.0007
164 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
165 APPLICATION SITE HAEMORRHAGE 2 0.0007
166 ABASIA 18 0.0007
167 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
168 RASH MORBILLIFORM 2 0.0007
169 TRICHORRHEXIS 2 0.0007
170 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
171 THERMAL BURN 5 0.0007
172 BLOOD ELECTROLYTES DECREASED 1 0.0007
173 PURULENT DISCHARGE 3 0.0007
174 LIP PAIN 2 0.0007
175 HORDEOLUM 3 0.0007
176 HEPATIC CIRRHOSIS 13 0.0007
177 METABOLIC DISORDER 4 0.0007
178 LOSS OF EMPLOYMENT 2 0.0007
179 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
180 DYSCHEZIA 2 0.0007
181 MASTICATION DISORDER 2 0.0007
182 ISCHAEMIA 3 0.0007
183 CHRONIC MYELOID LEUKAEMIA 3 0.0006
184 SYNOVIAL CYST 3 0.0006
185 PRE-EXISTING CONDITION IMPROVED 4 0.0006
186 BLOOD BLISTER 2 0.0006
187 BACTERIAL VAGINOSIS 1 0.0006
188 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
189 APPLICATION SITE PAIN 14 0.0006
190 SKIN ABRASION 3 0.0006
191 NON-CARDIAC CHEST PAIN 2 0.0006
192 STUPOR 2 0.0006
193 HUMERUS FRACTURE 3 0.0006
194 ACUTE LEUKAEMIA 1 0.0006
195 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
196 BACTERIAL SEPSIS 2 0.0006
197 OEDEMA MOUTH 2 0.0006
198 ANHEDONIA 16 0.0006
199 DEAFNESS NEUROSENSORY 2 0.0006
200 PRODUCT FORMULATION ISSUE 4 0.0006
201 ANTIBODY TEST POSITIVE 1 0.0006
202 DIABETIC RETINOPATHY 2 0.0006
203 REGURGITATION 2 0.0006
204 BLOOD CHLORIDE INCREASED 1 0.0006
205 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
206 BREAST CYST 1 0.0006
207 SKIN WEEPING 2 0.0006
208 GRAFT VERSUS HOST DISEASE 4 0.0006
209 END STAGE RENAL DISEASE 10 0.0005
210 SKIN LESION 15 0.0005
211 CHOKING SENSATION 3 0.0005
212 WOUND HAEMORRHAGE 2 0.0005
213 LEUKOENCEPHALOPATHY 2 0.0005
214 AURA 1 0.0005
215 PROTEIN TOTAL DECREASED 2 0.0005
216 MITRAL VALVE INCOMPETENCE 6 0.0005
217 ECONOMIC PROBLEM 8 0.0005
218 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
219 HERPES VIRUS INFECTION 3 0.0005
220 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
221 ORAL INFECTION 2 0.0005
222 HYPERLIPIDAEMIA 6 0.0005
223 HOMICIDAL IDEATION 2 0.0005
224 TOOTH ABSCESS 5 0.0005
225 DECUBITUS ULCER 4 0.0005
226 APPLICATION SITE EXFOLIATION 2 0.0005
227 SCOLIOSIS 3 0.0005
228 VENTRICULAR EXTRASYSTOLES 5 0.0005
229 HALLUCINATIONS, MIXED 2 0.0005
230 SCREAMING 3 0.0005
231 INADEQUATE ANALGESIA 4 0.0005
232 AORTIC VALVE INCOMPETENCE 2 0.0005
233 ABSCESS LIMB 2 0.0005
234 ENTERITIS 3 0.0005
235 ACUTE RESPIRATORY FAILURE 9 0.0005
236 BODY HEIGHT DECREASED 5 0.0005
237 BLOOD TESTOSTERONE INCREASED 1 0.0005
238 DECREASED ACTIVITY 5 0.0005
239 APPLICATION SITE SCAB 1 0.0005
240 APPLICATION SITE VESICLES 3 0.0005
241 CHAPPED LIPS 2 0.0005
242 CHRONIC KIDNEY DISEASE 35 0.0005
243 HIP ARTHROPLASTY 7 0.0005
244 BLOOD CALCIUM INCREASED 4 0.0005
245 ONYCHOMYCOSIS 2 0.0005
246 APPETITE DISORDER 3 0.0005
247 TOOTH DISORDER 10 0.0004
248 BRONCHIECTASIS 3 0.0004
249 COLITIS ISCHAEMIC 3 0.0004
250 PAPILLOEDEMA 2 0.0004
251 BLOOD LOSS ANAEMIA 1 0.0004
252 IMPAIRED DRIVING ABILITY 5 0.0004
253 BREAKTHROUGH PAIN 1 0.0004
254 NEPHROPATHY 4 0.0004
255 APPLICATION SITE REACTION 3 0.0004
256 ARTERIOSCLEROSIS 4 0.0004
257 VAGINAL INFECTION 2 0.0004
258 APPLICATION SITE ERYTHEMA 11 0.0004
259 BLOOD UREA INCREASED 7 0.0004
260 SUBCUTANEOUS ABSCESS 2 0.0004
261 FAECAL INCONTINENCE 2 0.0004
262 ATELECTASIS 4 0.0004
263 BREATH ODOUR 1 0.0004
264 SCAR 7 0.0004
265 APPLICATION SITE BURN 2 0.0004
266 HYPERVOLAEMIA 2 0.0004
267 EXPIRED DRUG ADMINISTERED 2 0.0004
268 DIABETIC NEUROPATHY 2 0.0004
269 PULMONARY MASS 6 0.0004
270 ORAL PAIN 9 0.0004
271 APPLICATION SITE SWELLING 2 0.0004
272 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
273 WOUND 11 0.0004
274 PETIT MAL EPILEPSY 2 0.0004
275 PERIPHERAL VASCULAR DISORDER 2 0.0004
276 MUSCULOSKELETAL CHEST PAIN 6 0.0004
277 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
278 SKIN NECROSIS 2 0.0004
279 ACTINIC KERATOSIS 1 0.0004
280 FAILURE TO THRIVE 2 0.0004
281 BLOOD ALBUMIN DECREASED 3 0.0004
282 TRICUSPID VALVE INCOMPETENCE 3 0.0004
283 NYSTAGMUS 2 0.0004
284 BLOOD POTASSIUM ABNORMAL 1 0.0004
285 HYPERKALAEMIA 13 0.0004
286 INJURY 26 0.0004
287 CHEILITIS 2 0.0004
288 ABDOMINAL RIGIDITY 1 0.0004
289 ANORGASMIA 1 0.0004
290 HYDROCEPHALUS 2 0.0004
291 ENCEPHALOPATHY 9 0.0004
292 FAECALOMA 2 0.0004
293 ESCHERICHIA INFECTION 3 0.0004
294 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
295 ASTHENOPIA 2 0.0004
296 HYPERKERATOSIS 2 0.0004
297 EXPIRED PRODUCT ADMINISTERED 12 0.0004
298 GASTRIC ULCER HAEMORRHAGE 2 0.0004
299 FUNGAL INFECTION 12 0.0004
300 CARPAL TUNNEL SYNDROME 5 0.0004
301 SKIN INFECTION 4 0.0004
302 TYPE 2 DIABETES MELLITUS 12 0.0004
303 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
304 EYE INFECTION 4 0.0004
305 DISABILITY 7 0.0004
306 MYOCARDIAL ISCHAEMIA 4 0.0004
307 HYPERTONIA 2 0.0003
308 IMPAIRED QUALITY OF LIFE 5 0.0003
309 ACUTE KIDNEY INJURY 53 0.0003
310 HYPERVENTILATION 2 0.0003
311 URINE OUTPUT DECREASED 3 0.0003
312 PRODUCT LABEL CONFUSION 2 0.0003
313 URINE ODOUR ABNORMAL 2 0.0003
314 LIVER DISORDER 15 0.0003
315 EAR INFECTION 9 0.0003
316 SKIN HAEMORRHAGE 5 0.0003
317 CELLULITIS 17 0.0003
318 SINUS HEADACHE 2 0.0003
319 BLOOD CULTURE POSITIVE 1 0.0003
320 GANGRENE 2 0.0003
321 LIP DRY 3 0.0003
322 SKIN DISORDER 11 0.0003
323 NOCTURIA 4 0.0003
324 CARDIOMEGALY 4 0.0003
325 NERVE COMPRESSION 3 0.0003
326 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
327 MULTIPLE INJURIES 2 0.0003
328 OBESITY 5 0.0003
329 RASH ERYTHEMATOUS 15 0.0003
330 SCIATICA 5 0.0003
331 DRUG PRESCRIBING ERROR 6 0.0003
332 SLEEP DISORDER 22 0.0003
333 PROCTALGIA 2 0.0003
334 SINUS BRADYCARDIA 3 0.0003
335 CARDIAC FLUTTER 2 0.0003
336 PARKINSONISM 3 0.0003
337 HAEMORRHOIDS 6 0.0003
338 PLATELET COUNT INCREASED 4 0.0003
339 INFLAMMATORY BOWEL DISEASE 3 0.0003
340 RENAL TUBULAR NECROSIS 3 0.0003
341 SKIN IRRITATION 14 0.0003
342 MUCOSAL INFLAMMATION 8 0.0003
343 PULMONARY CONGESTION 4 0.0003
344 WALKING AID USER 2 0.0003
345 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
346 COAGULOPATHY 5 0.0003
347 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
348 CORONARY ARTERY DISEASE 9 0.0003
349 ULCER HAEMORRHAGE 2 0.0003
350 APPLICATION SITE DRYNESS 1 0.0003
351 IMPAIRED GASTRIC EMPTYING 4 0.0003
352 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
353 BLOOD TESTOSTERONE DECREASED 2 0.0003
354 INTESTINAL OBSTRUCTION 11 0.0003
355 CROHN'S DISEASE 2 0.0003
356 ECCHYMOSIS 2 0.0003
357 TEMPERATURE INTOLERANCE 3 0.0003
358 DROOLING 2 0.0003
359 MENTAL STATUS CHANGES 8 0.0003
360 AORTIC STENOSIS 1 0.0003
361 WEIGHT FLUCTUATION 3 0.0003
362 EXTRASYSTOLES 2 0.0003
363 PAPULE 2 0.0003
364 INCONTINENCE 3 0.0003
365 BRADYCARDIA 15 0.0003
366 DIVERTICULUM 2 0.0003
367 MOVEMENT DISORDER 9 0.0003
368 RED BLOOD CELL COUNT DECREASED 8 0.0003
369 BONE LESION 1 0.0003
370 LEUKOCYTOSIS 5 0.0003
371 BIPOLAR DISORDER 3 0.0003
372 SEPTIC SHOCK 12 0.0003
373 PULMONARY THROMBOSIS 3 0.0003
374 OESOPHAGITIS 3 0.0003
375 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
376 MAJOR DEPRESSION 2 0.0003
377 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
378 BLOOD CALCIUM DECREASED 3 0.0003
379 PHOTOPHOBIA 5 0.0003
380 DERMATITIS CONTACT 3 0.0003
381 MICTURITION URGENCY 3 0.0003
382 CHOLECYSTECTOMY 3 0.0003
383 SLEEP APNOEA SYNDROME 5 0.0003
384 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
385 NEOPLASM 3 0.0003
386 RENAL FAILURE CHRONIC 2 0.0003
387 DELIRIUM 9 0.0003
388 PNEUMONITIS 7 0.0003
389 ORAL HERPES 5 0.0003
390 SKIN FISSURES 5 0.0003
391 PULMONARY HAEMORRHAGE 2 0.0003
392 KIDNEY INFECTION 5 0.0003
393 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
394 FURUNCLE 2 0.0003
395 CATARACT 15 0.0003
396 HAEMOPTYSIS 7 0.0003
397 MUSCLE RIGIDITY 3 0.0003
398 ATRIAL FLUTTER 2 0.0003
399 AZOTAEMIA 1 0.0003
400 RENAL FAILURE 33 0.0002
401 PRODUCT ADMINISTRATION ERROR 5 0.0002
402 PAIN IN JAW 7 0.0002
403 POST PROCEDURAL INFECTION 2 0.0002
404 ABNORMAL FAECES 2 0.0002
405 SMALL INTESTINAL OBSTRUCTION 3 0.0002
406 IMPAIRED HEALING 8 0.0002
407 RIB FRACTURE 5 0.0002
408 ANXIETY 69 0.0002
409 SPINAL COMPRESSION FRACTURE 2 0.0002
410 CYST 3 0.0002
411 DRUG LEVEL INCREASED 4 0.0002
412 ILEUS 3 0.0002
413 LIVER FUNCTION TEST ABNORMAL 7 0.0002
414 DERMATITIS 5 0.0002
415 UTERINE PERFORATION 2 0.0002
416 BUNDLE BRANCH BLOCK LEFT 1 0.0002
417 RENAL INJURY 7 0.0002
418 EATING DISORDER 5 0.0002
419 ANOREXIA 3 0.0002
420 SKIN ULCER 6 0.0002
421 BLOOD MAGNESIUM DECREASED 2 0.0002
422 HIATUS HERNIA 3 0.0002
423 CARDIAC MURMUR 2 0.0002
424 PLEURAL EFFUSION 14 0.0002
425 BONE CANCER 1 0.0002
426 ARTHRITIS 18 0.0002
427 NAIL DISORDER 2 0.0002
428 BEDRIDDEN 3 0.0002
429 BURNING SENSATION 16 0.0002
430 GASTRITIS 6 0.0002
431 ORAL CANDIDIASIS 3 0.0002
432 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
433 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
434 PSORIATIC ARTHROPATHY 9 0.0002
435 OPTIC NEURITIS 2 0.0002
436 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
437 ABDOMINAL HERNIA 1 0.0002
438 EXOSTOSIS 2 0.0002
439 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
440 APPLICATION SITE RASH 3 0.0002
441 PNEUMONIA BACTERIAL 2 0.0002
442 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
443 DYSURIA 8 0.0002
444 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
445 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
446 PERICARDIAL EFFUSION 5 0.0002
447 ATRIAL FIBRILLATION 21 0.0002
448 ARTHRITIS INFECTIVE 1 0.0002
449 BACTERIAL INFECTION 4 0.0002
450 COGNITIVE DISORDER 10 0.0002
451 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
452 FLANK PAIN 2 0.0002
453 OEDEMA PERIPHERAL 26 0.0002
454 LACERATION 2 0.0002
455 SQUAMOUS CELL CARCINOMA 2 0.0002
456 RENAL FAILURE ACUTE 9 0.0002
457 BLOOD PROLACTIN INCREASED 1 0.0002
458 LEUKAEMIA 2 0.0002
459 SPUTUM DISCOLOURED 2 0.0002
460 BLOOD URINE PRESENT 4 0.0002
461 LIP SWELLING 7 0.0002
462 LOCALISED INFECTION 5 0.0002
463 PRESCRIBED OVERDOSE 4 0.0002
464 EMOTIONAL DISTRESS 25 0.0002
465 DIZZINESS POSTURAL 2 0.0002
466 CHOKING 4 0.0002
467 PHARYNGEAL SWELLING 2 0.0002
468 DRUG EFFECT DECREASED 11 0.0002
469 GASTRIC DISORDER 7 0.0002
470 COELIAC DISEASE 2 0.0002
471 LIVER INJURY 5 0.0002
472 KNEE OPERATION 2 0.0002
473 BODY TEMPERATURE DECREASED 2 0.0002
474 RASH PRURITIC 11 0.0002
475 BREATH SOUNDS ABNORMAL 1 0.0002
476 URINARY INCONTINENCE 6 0.0002
477 LIGAMENT SPRAIN 2 0.0002
478 ABDOMINAL TENDERNESS 1 0.0002
479 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
480 ANEURYSM 1 0.0002
481 UPPER LIMB FRACTURE 4 0.0002
482 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
483 ADVERSE DRUG REACTION 18 0.0002
484 RASH MACULAR 7 0.0002
485 SALIVARY HYPERSECRETION 2 0.0002
486 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
487 OSTEOPENIA 3 0.0002
488 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
489 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
490 CONSTIPATION 43 0.0002
491 PRODUCT USE ISSUE 37 0.0002
492 MOTOR DYSFUNCTION 2 0.0002
493 INSURANCE ISSUE 3 0.0002
494 AMMONIA INCREASED 1 0.0002
495 EAR DISCOMFORT 2 0.0002
496 ERECTILE DYSFUNCTION 5 0.0002
497 LUNG INFECTION 3 0.0002
498 BLOOD CHOLESTEROL INCREASED 9 0.0002
499 HAEMATOMA 5 0.0002
500 EYE DISCHARGE 2 0.0002
501 C-REACTIVE PROTEIN INCREASED 7 0.0002
502 POLLAKIURIA 8 0.0002
503 PRODUCT ODOUR ABNORMAL 2 0.0002
504 FOLLICULITIS 2 0.0002
505 PRODUCT USE COMPLAINT 3 0.0002
506 HALLUCINATION, VISUAL 4 0.0002
507 RENAL PAIN 2 0.0002
508 PRODUCTIVE COUGH 9 0.0002
509 ANAL FISTULA 1 0.0002
510 ANAL FISSURE 1 0.0002
511 POOR QUALITY SLEEP 4 0.0002
512 PRURITUS GENERALISED 4 0.0002
513 PHARYNGITIS STREPTOCOCCAL 2 0.0002
514 DEEP VEIN THROMBOSIS 12 0.0002
515 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
516 SKIN LACERATION 2 0.0002
517 WOUND INFECTION 2 0.0002
518 ASPIRATION 2 0.0002
519 MULTIPLE FRACTURES 3 0.0002
520 EYE DISORDER 6 0.0002
521 STAPHYLOCOCCAL INFECTION 6 0.0002
522 URINARY TRACT INFECTION 31 0.0002
523 DENTAL CARIES 2 0.0002
524 BACK PAIN 42 0.0002
525 FOOT DEFORMITY 2 0.0002
526 FEELING COLD 5 0.0002
527 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
528 EYE PRURITUS 6 0.0002
529 ANGIOPATHY 1 0.0002
530 ACUTE PULMONARY OEDEMA 1 0.0002
531 CHROMATURIA 4 0.0002
532 MYALGIA 30 0.0002
533 APPLICATION SITE PRURITUS 4 0.0002
534 SCAB 2 0.0002
535 MYOCARDITIS 2 0.0002
536 PARANOIA 3 0.0002
537 MULTI-ORGAN FAILURE 3 0.0002
538 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
539 MADAROSIS 2 0.0002
540 DYSSTASIA 5 0.0002
541 BONE PAIN 10 0.0002
542 SEPSIS 19 0.0002
543 COLD SWEAT 3 0.0002
544 OSTEOPOROSIS 7 0.0002
545 LYMPHADENOPATHY 6 0.0002
546 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
547 BRADYKINESIA 1 0.0002
548 BACTERAEMIA 2 0.0002
549 GALLBLADDER DISORDER 3 0.0002
550 DEPRESSION 38 0.0002
551 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
552 CHEST DISCOMFORT 17 0.0002
553 SKIN EXFOLIATION 14 0.0002
554 SINUSITIS 17 0.0002
555 LACRIMATION INCREASED 5 0.0002
556 DRUG EFFECT INCOMPLETE 6 0.0002
557 HYPERGLYCAEMIA 6 0.0002
558 RESPIRATORY FAILURE 12 0.0002
559 FIBROMYALGIA 4 0.0002
560 NEURALGIA 4 0.0002
561 DISCOMFORT 10 0.0002
562 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
563 LUNG DISORDER 8 0.0002
564 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
565 SPINAL OPERATION 2 0.0002
566 CONJUNCTIVITIS 3 0.0002
567 MIDDLE INSOMNIA 3 0.0002
568 SECRETION DISCHARGE 2 0.0002
569 PAIN 98 0.0002
570 DYSPNOEA EXERTIONAL 6 0.0002
571 COLITIS 6 0.0002
572 DYSPHAGIA 15 0.0002
573 GASTRIC CANCER 4 0.0002
574 PROTEINURIA 3 0.0002
575 CYSTITIS 5 0.0002
576 PULMONARY OEDEMA 7 0.0002
577 GASTROINTESTINAL DISORDER 14 0.0002
578 HYPERTENSION 33 0.0002
579 GENITAL HAEMORRHAGE 2 0.0002
580 UNRESPONSIVE TO STIMULI 4 0.0002
581 RENAL IMPAIRMENT 13 0.0002
582 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
583 DIPLOPIA 4 0.0002
584 DEAFNESS 4 0.0002
585 ASPERGILLUS INFECTION 1 0.0002
586 TOOTH INFECTION 2 0.0002
587 HYPOKALAEMIA 7 0.0002
588 SINUS DISORDER 3 0.0002
589 ABNORMAL BEHAVIOUR 6 0.0002
590 PNEUMONIA 49 0.0002
591 ADVERSE REACTION 2 0.0002
592 DEHYDRATION 20 0.0001
593 EYE HAEMORRHAGE 2 0.0001
594 MALIGNANT MELANOMA 2 0.0001
595 QUALITY OF LIFE DECREASED 2 0.0001
596 BREAST MASS 1 0.0001
597 FEAR 4 0.0001
598 SINUS CONGESTION 2 0.0001
599 OEDEMA 8 0.0001
600 NEUTROPHIL COUNT DECREASED 6 0.0001
601 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
602 ABNORMAL LOSS OF WEIGHT 1 0.0001
603 ORAL DISCOMFORT 2 0.0001
604 HUNGER 2 0.0001
605 INTENTIONAL DRUG MISUSE 3 0.0001
606 APHONIA 2 0.0001
607 NECK PAIN 8 0.0001
608 MASS 2 0.0001
609 BLISTER 8 0.0001
610 BLOOD TEST ABNORMAL 2 0.0001
611 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
612 TARDIVE DYSKINESIA 4 0.0001
613 LYMPHOPENIA 2 0.0001
614 FLATULENCE 8 0.0001
615 NASOPHARYNGITIS 26 0.0001
616 DIALYSIS 2 0.0001
617 JOINT INJURY 3 0.0001
618 IMPAIRED WORK ABILITY 3 0.0001
619 RECTAL HAEMORRHAGE 6 0.0001
620 ANGINA PECTORIS 4 0.0001
621 HYPOTENSION 28 0.0001
622 HYPERSOMNIA 4 0.0001
623 PAIN IN EXTREMITY 41 0.0001
624 PARAESTHESIA ORAL 2 0.0001
625 MYELODYSPLASTIC SYNDROME 2 0.0001
626 SWELLING FACE 9 0.0001
627 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
628 APATHY 2 0.0001
629 CARDIAC FAILURE CONGESTIVE 11 0.0001
630 INSOMNIA 36 0.0001
631 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
632 ARTHROPOD BITE 1 0.0001
633 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
634 RESPIRATORY DISORDER 4 0.0001
635 EPISTAXIS 10 0.0001
636 MUSCULOSKELETAL PAIN 7 0.0001
637 ASTHENIA 50 0.0001
638 HYPOAESTHESIA ORAL 2 0.0001
639 JOINT SWELLING 16 0.0001
640 APHASIA 4 0.0001
641 DYSPEPSIA 13 0.0001
642 HEPATIC ENZYME INCREASED 9 0.0001
643 MUSCULAR WEAKNESS 15 0.0001
644 DEVICE FAILURE 2 0.0001
645 URTICARIA 22 0.0001
646 DIABETES MELLITUS 10 0.0001
647 DYSPNOEA 74 0.0001
648 SKIN DISCOLOURATION 6 0.0001
649 SHOCK 3 0.0001
650 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
651 PHARYNGEAL OEDEMA 2 0.0001
652 THYROID DISORDER 2 0.0001
653 EMOTIONAL DISORDER 4 0.0001
654 LYMPHOMA 2 0.0001
655 TENDONITIS 2 0.0001
656 WEIGHT DECREASED 36 0.0001
657 APHTHOUS ULCER 1 0.0001
658 DELUSION 2 0.0001
659 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
660 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
661 APNOEA 1 0.0001
662 SWELLING 12 0.0001
663 HAEMOGLOBIN DECREASED 13 0.0001
664 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
665 ERYTHEMA 26 0.0001
666 HEAD INJURY 4 0.0001
667 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
668 ARTHROPATHY 7 0.0001
669 ULCER 2 0.0001
670 MUSCULOSKELETAL STIFFNESS 11 0.0001
671 ABSCESS 2 0.0001
672 PRODUCT QUALITY ISSUE 17 0.0001
673 METABOLIC ACIDOSIS 4 0.0001
674 CONTUSION 12 0.0001
675 OXYGEN SATURATION DECREASED 7 0.0001
676 HIP FRACTURE 4 0.0001
677 RHINORRHOEA 8 0.0001
678 MENTAL IMPAIRMENT 3 0.0001
679 DRY MOUTH 10 0.0001
680 LETHARGY 7 0.0001
681 EYE IRRITATION 7 0.0001
682 BRONCHITIS 9 0.0001
683 HEART RATE INCREASED 12 0.0001
684 DRY EYE 6 0.0001
685 VIRAL INFECTION 4 0.0001
686 PNEUMONIA ASPIRATION 3 0.0001
687 URINARY RETENTION 4 0.0001
688 PRURITUS 46 0.0001
689 GAIT INABILITY 4 0.0001
690 ABDOMINAL PAIN LOWER 3 0.0001
691 CANDIDA INFECTION 2 0.0001
692 HAEMATEMESIS 3 0.0001
693 ARTHRALGIA 49 0.0001
694 HYPOPHAGIA 3 0.0001
695 HEPATITIS 3 0.0001
696 VOMITING 55 0.0001
697 THERAPY CESSATION 6 0.0001
698 DRUG RESISTANCE 3 0.0001
699 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
700 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
701 IRRITABILITY 7 0.0001
702 RASH GENERALISED 3 0.0001
703 NEUROPATHY PERIPHERAL 11 0.0001
704 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
705 RESPIRATORY TRACT INFECTION 3 0.0001
706 CONDITION AGGRAVATED 35 0.0001
707 DEVICE DISLOCATION 5 0.0001
708 GAIT DISTURBANCE 22 0.0001
709 NERVOUSNESS 6 0.0001
710 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
711 METASTASES TO LIVER 2 0.0001
712 BREAST CANCER FEMALE 3 0.0001
713 THROMBOSIS 9 0.0001
714 JAUNDICE 3 0.0001
715 GOUT 2 0.0001
716 MOBILITY DECREASED 8 0.0001
717 GASTROENTERITIS VIRAL 2 0.0001
718 TOOTHACHE 2 0.0001
719 FATIGUE 86 0.0001
720 PALLOR 3 0.0001
721 RESTLESSNESS 4 0.0001
722 RESPIRATORY DISTRESS 3 0.0001
723 DIVERTICULITIS 3 0.0001
724 RASH 47 0.0001
725 HYPERSENSITIVITY 20 0.0001
726 AGRANULOCYTOSIS 2 0.0001
727 HEPATIC STEATOSIS 2 0.0001
728 DEMENTIA 3 0.0001
729 ABDOMINAL DISCOMFORT 18 0.0001
730 BLOOD CREATININE INCREASED 7 0.0001
731 APPENDICITIS 1 0.0001
732 HYPONATRAEMIA 6 0.0001
733 DYSARTHRIA 4 0.0001
734 FRACTURE 2 0.0001
735 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
736 OCULAR HYPERAEMIA 5 0.0001
737 GASTRIC ULCER 2 0.0001
738 NAUSEA 83 0.0001
739 PULMONARY FIBROSIS 2 0.0001
740 AFFECT LABILITY 1 0.0001
741 PERIPHERAL SWELLING 16 0.0001
742 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
743 HERNIA 2 0.0001
744 COUGH 29 0.0001
745 DECREASED APPETITE 24 0.0001
746 EAR PAIN 2 0.0001
747 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
748 DIARRHOEA 66 0.0001
749 NASAL CONGESTION 6 0.0001
750 ASCITES 3 0.0001
751 LABORATORY TEST ABNORMAL 3 0.0001
752 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
753 DISEASE PROGRESSION 12 0.0001
754 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
755 HAEMATOCRIT DECREASED 2 0.0001
756 BLOOD GLUCOSE INCREASED 19 0.0001
757 BLADDER DISORDER 1 0.0001
758 SPINAL FRACTURE 2 0.0001
759 SOMNOLENCE 20 0.0001
760 EXTRA DOSE ADMINISTERED 4 0.0001
761 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
762 DYSKINESIA 4 0.0001
763 BLOOD PRESSURE INCREASED 15 0.0001
764 OROPHARYNGEAL PAIN 9 0.0001
765 GYNAECOMASTIA 3 0.0001
766 LIMB DISCOMFORT 3 0.0001
767 RHEUMATOID ARTHRITIS 11 0.0001
768 ALOPECIA 19 0.0001
769 PERITONITIS 2 0.0001
770 TOOTH LOSS 2 0.0001
771 DIZZINESS 48 0.0001
772 CARDIAC DISORDER 9 0.0001
773 FALL 32 0.0001
774 NERVOUS SYSTEM DISORDER 3 0.0001
775 PULMONARY HYPERTENSION 2 0.0001
776 ABDOMINAL DISTENSION 10 0.0001
777 ROAD TRAFFIC ACCIDENT 4 0.0001
778 SPEECH DISORDER 5 0.0001
779 PARAESTHESIA 15 0.0001
780 PULMONARY EMBOLISM 9 0.0001
781 DRUG INTERACTION 15 0.0001
782 OSTEOARTHRITIS 4 0.0001
783 MOOD SWINGS 3 0.0001
784 HYPOTHYROIDISM 3 0.0001
785 PALPITATIONS 11 0.0001
786 RETCHING 2 0.0001
787 WEIGHT INCREASED 21 0.0001
788 BREAST PAIN 1 0.0001
789 HYPOAESTHESIA 14 0.0001
790 IRRITABLE BOWEL SYNDROME 2 0.0001
791 BREAST CANCER METASTATIC 1 0.0001
792 NIGHT SWEATS 3 0.0001
793 SKIN CANCER 2 0.0001
794 MUSCLE SPASMS 17 0.0001
795 ABDOMINAL PAIN UPPER 19 0.0001
796 AMNESIA 6 0.0001
797 BACK INJURY 1 0.0001
798 INTENTIONAL PRODUCT MISUSE 8 0.0001
799 BLOOD GLUCOSE FLUCTUATION 1 0.0001
800 HEADACHE 57 0.0001
801 BLOOD PRESSURE DECREASED 6 0.0001
802 ABDOMINAL PAIN 21 0.0001
803 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
804 STEVENS-JOHNSON SYNDROME 2 0.0001
805 NEOPLASM MALIGNANT 6 0.0001
806 INFLUENZA 10 0.0001
807 COLITIS ULCERATIVE 4 0.0001
808 PANCYTOPENIA 5 0.0001
809 GLOSSODYNIA 2 0.0001
810 SNEEZING 2 0.0001
811 THROAT IRRITATION 4 0.0001
812 PANCREATITIS ACUTE 2 0.0001
813 DRUG INEFFECTIVE 117 0.0001
814 ANGER 3 0.0001
815 HEART RATE IRREGULAR 2 0.0001
816 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
817 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
818 FEELING ABNORMAL 21 0.0001
819 CONVULSION 5 0.0001
820 MUSCLE TWITCHING 2 0.0001
821 NIGHTMARE 3 0.0001
822 NEOPLASM PROGRESSION 3 0.0001
823 RENAL DISORDER 4 0.0001
824 HEART RATE DECREASED 3 0.0001
825 CHILLS 10 0.0001
826 HYPOXIA 3 0.0001
827 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
828 TREMOR 14 0.0001
829 BLOOD IRON DECREASED 1 0.0001
830 ATAXIA 1 0.0001
831 PSORIASIS 11 0.0001
832 DISEASE RECURRENCE 4 0.0001
833 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
834 DIABETIC KETOACIDOSIS 2 0.0001
835 HEPATIC CANCER 2 0.0001
836 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
837 CRYING 3 0.0001
838 STOMATITIS 5 0.0001
839 ADRENAL INSUFFICIENCY 1 0.0001
840 PANIC ATTACK 3 0.0001
841 BALANCE DISORDER 7 0.0001
842 OSTEONECROSIS OF JAW 2 0.0001
843 CONFUSIONAL STATE 13 0.0001
844 APPLICATION SITE IRRITATION 1 0.0001
845 VISION BLURRED 11 0.0001
846 UNEVALUABLE EVENT 6 0.0001
847 PRODUCT COMPLAINT 2 0.0001
848 CARDIOVASCULAR DISORDER 2 0.0001
849 SEIZURE 9 0.0001
850 MALAISE 34 0.0001
851 HAEMORRHAGE 8 0.0001
852 SUICIDAL IDEATION 7 0.0001
853 SEDATION 2 0.0001
854 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
855 PYREXIA 26 0.0001
856 INJECTION SITE HAEMORRHAGE 6 0.0001
857 PAIN OF SKIN 2 0.0001
858 DISTURBANCE IN ATTENTION 4 0.0001
859 THROAT TIGHTNESS 2 0.0001
860 LIMB INJURY 2 0.0001
861 BLINDNESS 3 0.0001
862 ANAEMIA 14 0.0001
863 AKATHISIA 1 0.0001
864 TREATMENT NONCOMPLIANCE 4 0.0001
865 LUNG NEOPLASM MALIGNANT 3 0.0001
866 INFLUENZA LIKE ILLNESS 6 0.0001
867 CARDIAC ARREST 6 0.0001
868 ABNORMAL DREAMS 2 0.0001
869 PROCEDURAL PAIN 2 0.0001
870 CARDIO-RESPIRATORY ARREST 3 0.0001
871 WITHDRAWAL SYNDROME 3 0.0001
872 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
873 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
874 BRONCHOSPASM 1 0.0001
875 SYNCOPE 7 0.0001
876 HYPOACUSIS 3 0.0001
877 HERPES ZOSTER 4 0.0001
878 PANCREATIC CARCINOMA 2 0.0001
879 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
880 ANGIOEDEMA 3 0.0001
881 DRY SKIN 9 0.0001
882 OFF LABEL USE 59 0.0001
883 DYSGEUSIA 5 0.0001
884 DRUG DOSE OMISSION 11 0.0001
885 BLOOD POTASSIUM DECREASED 2 0.0001
886 HALLUCINATION 5 0.0001
887 NEUTROPENIA 9 0.0001
888 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
889 BLOOD COUNT ABNORMAL 1 0.0001
890 MEMORY IMPAIRMENT 9 0.0001
891 DRUG ADMINISTRATION ERROR 2 0.0001
892 CEREBROVASCULAR ACCIDENT 11 0.0001
893 CHEST PAIN 12 0.0001
894 ANKLE FRACTURE 1 0.0001
895 ACUTE MYELOID LEUKAEMIA 1 0.0001
896 BASAL CELL CARCINOMA 1 0.0001
897 SWOLLEN TONGUE 2 0.0001
898 BONE DENSITY DECREASED 2 0.0001
899 BRAIN FOG 1 0.0001
900 ARRHYTHMIA 3 0.0001
901 MIGRAINE 6 0.0001
902 MULTIPLE SCLEROSIS 3 0.0001
903 BLOOD GLUCOSE DECREASED 3 0.0001
904 LACTIC ACIDOSIS 2 0.0001
905 BACK DISORDER 1 0.0001
906 VISUAL ACUITY REDUCED 2 0.0001
907 AGGRESSION 3 0.0001
908 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
909 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
910 FLUID RETENTION 3 0.0001
911 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
912 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
913 ILLNESS 6 0.0001
914 INFLAMMATION 3 0.0001
915 DEVICE USE ERROR 2 0.0001
916 ECZEMA 3 0.0001
917 PANCREATITIS 3 0.0001
918 VISUAL IMPAIRMENT 7 0.0001
919 PLATELET COUNT DECREASED 6 0.0001
920 TACHYCARDIA 5 0.0001
921 BONE DISORDER 1 0.0001
922 UNDERDOSE 4 0.0001
923 ACCIDENTAL OVERDOSE 2 0.0001
924 HAEMATOCHEZIA 3 0.0001
925 EYE SWELLING 2 0.0001
926 EYE PAIN 3 0.0001
927 HOT FLUSH 4 0.0001
928 BLOOD SODIUM DECREASED 1 0.0001
929 ACNE 4 0.0001
930 INJECTION SITE SWELLING 4 0.0001
931 MYOCARDIAL INFARCTION 9 0.0001
932 DYSPHONIA 3 0.0001
933 SURGERY 3 0.0001
934 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
935 BLOOD PRESSURE ABNORMAL 1 0.0001
936 INJECTION SITE BRUISING 4 0.0001
937 ILL-DEFINED DISORDER 3 0.0000
938 BONE MARROW FAILURE 1 0.0000
939 BODY TEMPERATURE INCREASED 1 0.0000
940 INJECTION SITE ERYTHEMA 6 0.0000
941 INFECTION 7 0.0000
942 INCORRECT DOSE ADMINISTERED 11 0.0000
943 LOSS OF CONSCIOUSNESS 6 0.0000
944 HYPERHIDROSIS 6 0.0000
945 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
946 MENTAL DISORDER 2 0.0000
947 COVID-19 8 0.0000
948 INFUSION RELATED REACTION 3 0.0000
949 FEBRILE NEUTROPENIA 3 0.0000
950 THROMBOCYTOPENIA 5 0.0000
951 DEVICE ISSUE 4 0.0000
952 THERAPY NON-RESPONDER 2 0.0000
953 NEPHROLITHIASIS 2 0.0000
954 DRUG DEPENDENCE 7 0.0000
955 TINNITUS 2 0.0000
956 ADVERSE EVENT 4 0.0000
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
958 BLOOD PRESSURE FLUCTUATION 1 0.0000
959 DRUG INTOLERANCE 4 0.0000
960 AGEUSIA 1 0.0000
961 LEUKOPENIA 2 0.0000
962 ANAPHYLACTIC SHOCK 1 0.0000
963 DEPRESSED MOOD 2 0.0000
964 CARDIAC FAILURE 3 0.0000
965 PROSTATE CANCER 3 0.0000
966 BLOOD BILIRUBIN INCREASED 1 0.0000
967 MEDICATION ERROR 2 0.0000
968 ASTHMA 4 0.0000
969 PRODUCT DOSE OMISSION ISSUE 10 0.0000
970 THERAPEUTIC RESPONSE DECREASED 2 0.0000
971 SUICIDE ATTEMPT 2 0.0000
972 VERTIGO 2 0.0000
973 FEELING HOT 2 0.0000
974 HOSPITALISATION 5 0.0000
975 BREAST CANCER 3 0.0000
976 INJECTION SITE REACTION 2 0.0000
977 DEVICE MALFUNCTION 2 0.0000
978 THERAPY INTERRUPTED 2 0.0000
979 SKIN BURNING SENSATION 2 0.0000
980 OVERDOSE 6 0.0000
981 AGITATION 2 0.0000
982 ABORTION SPONTANEOUS 1 0.0000
983 DRUG ABUSE 2 0.0000
984 PRODUCT STORAGE ERROR 2 0.0000
985 INJECTION SITE PAIN 7 0.0000
986 DRUG WITHDRAWAL SYNDROME 2 0.0000
987 NO ADVERSE EVENT 4 0.0000
988 DEATH 18 0.0000
989 FLUSHING 2 0.0000
990 ANAPHYLACTIC REACTION 1 0.0000
991 TOXICITY TO VARIOUS AGENTS 3 0.0000